当前位置: X-MOL 学术Nat. Rev. Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Thyroid cancer: CAR T cell therapy — potential in advanced thyroid cancer?
Nature Reviews Endocrinology ( IF 40.5 ) Pub Date : 2017-11-24 , DOI: 10.1038/nrendo.2017.160
Jena D. French , Bryan R. Haugen

Thyroid cancer: CAR T cell therapy — potential in advanced thyroid cancer?

Thyroid cancer: CAR T cell therapy — potential in advanced thyroid cancer?, Published online: 24 November 2017; doi:10.1038/nrendo.2017.160

In the current era of immunotherapy successes, Min and colleagues report the promising preclinical development and efficacy of a CAR T cell therapy that recognizes ICAM-1, which is highly expressed in advanced thyroid cancers. Herein, we discuss the feasibility of this approach and its implications for future therapies to treat thyroid cancer.


中文翻译:

甲状腺癌:CAR T细胞疗法-晚期甲状腺癌有潜力吗?

甲状腺癌:CAR T细胞疗法-晚期甲状腺癌有潜力吗?

甲状腺癌:CAR T细胞疗法-晚期甲状腺癌的潜能?,在线发表:2017年11月24日;doi:10.1038 / nrendo.2017.160

在当前的免疫治疗成功时代,Min及其同事报告了一种可识别的ICAM-1的CAR T细胞疗法的临床前发展前景和功效,该ICAM-1在晚期甲状腺癌中高度表达。在这里,我们讨论这种方法的可行性及其对未来治疗甲状腺癌的治疗方法的意义。
更新日期:2017-11-24
down
wechat
bug